Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,804 | 744 | 99.8% |
| Education | $26.17 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,883 | 122 | $0 (2024) |
| PFIZER INC. | $1,496 | 87 | $0 (2024) |
| ABBVIE INC. | $1,403 | 82 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,038 | 66 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $853.49 | 43 | $0 (2024) |
| Lilly USA, LLC | $740.23 | 45 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $734.55 | 43 | $0 (2024) |
| Amgen Inc. | $630.98 | 33 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $598.85 | 36 | $0 (2023) |
| Allergan, Inc. | $336.93 | 23 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,901 | 94 | Novo Nordisk Inc ($456.03) |
| 2023 | $1,906 | 94 | PFIZER INC. ($321.22) |
| 2022 | $1,508 | 84 | Novo Nordisk Inc ($253.03) |
| 2021 | $1,813 | 103 | AbbVie Inc. ($398.47) |
| 2020 | $1,301 | 82 | Novo Nordisk Inc ($224.20) |
| 2019 | $1,341 | 84 | AstraZeneca Pharmaceuticals LP ($242.13) |
| 2018 | $1,199 | 82 | Boehringer Ingelheim Pharmaceuticals, Inc. ($162.60) |
| 2017 | $1,861 | 125 | AbbVie, Inc. ($229.99) |
All Payment Transactions
748 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: DIABETES | ||||||
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: PAIN | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Obesity | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Neurology | ||||||
| 11/26/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: VACCINES | ||||||
| 11/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Neuromodulation | ||||||
| 11/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: DIABETES | ||||||
| 10/16/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Obesity | ||||||
| 10/14/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Bone Health | ||||||
| 10/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Obesity | ||||||
| 09/19/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,521 | 1,900 | $357,249 | $126,686 |
| 2022 | 16 | 1,239 | 1,653 | $341,778 | $124,467 |
| 2021 | 13 | 1,164 | 1,429 | $332,641 | $128,343 |
| 2020 | 13 | 957 | 1,181 | $303,447 | $98,756 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 300 | 468 | $142,272 | $44,665 | 31.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 245 | 245 | $87,710 | $35,476 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 185 | 265 | $54,590 | $18,784 | 34.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 28 | 32 | $20,960 | $7,734 | 36.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 210 | 210 | $10,710 | $4,460 | 41.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 21 | 22 | $10,208 | $3,957 | 38.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 199 | 281 | $2,760 | $2,298 | 83.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $6,006 | $2,218 | 36.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 28 | 28 | $4,648 | $2,117 | 45.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 24 | $3,624 | $1,086 | 30.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 32 | 66 | $2,508 | $1,071 | 42.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 98 | 100 | $6,700 | $1,055 | 15.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $2,044 | $969.64 | 47.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 62 | 63 | $1,008 | $276.33 | 27.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 23 | 25 | $825.00 | $238.00 | 28.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 14 | 14 | $532.00 | $226.80 | 42.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 16 | 16 | $144.00 | $54.56 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 298 | 491 | $149,264 | $49,879 | 33.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 251 | 251 | $89,673 | $37,580 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 169 | 240 | $49,440 | $17,636 | 35.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 29 | 30 | $19,650 | $7,699 | 39.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 14 | 14 | $6,468 | $2,675 | 41.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 12 | 13 | $6,032 | $2,476 | 41.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 22 | 22 | $3,586 | $1,508 | 42.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 109 | 111 | $7,437 | $1,233 | 16.6% |
About Dr. Adil Ghauri, M.D
Dr. Adil Ghauri, M.D is a Internal Medicine healthcare provider based in Fairfax, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689671414.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adil Ghauri, M.D has received a total of $12,830 in payments from pharmaceutical and medical device companies, with $1,901 received in 2024. These payments were reported across 748 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($12,804).
As a Medicare-enrolled provider, Ghauri has provided services to 4,881 Medicare beneficiaries, totaling 6,163 services with total Medicare billing of $478,252. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Fairfax, VA
- Active Since 07/07/2005
- Last Updated 08/23/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1689671414
Products in Payments
- Ozempic (Drug) $831.65
- XARELTO (Drug) $693.42
- FARXIGA (Drug) $584.53
- JARDIANCE (Drug) $569.54
- UBRELVY (Drug) $500.11
- NURTEC ODT (Drug) $451.99
- ELIQUIS (Drug) $371.04
- Wegovy (Drug) $360.51
- SYNTHROID (Drug) $304.42
- Rybelsus (Drug) $302.45
- TRADJENTA (Drug) $302.04
- APLENZIN (Drug) $285.78
- TRULICITY (Drug) $270.26
- Synthroid (Drug) $256.04
- SOLIQUA 100/33 (Biological) $248.40
- PREVNAR 20 (Biological) $234.73
- MOUNJARO (Drug) $232.30
- VRAYLAR (Drug) $217.87
- EVENITY (Biological) $216.78
- CHANTIX (Drug) $211.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fairfax
Samim Enayat, Md, MD
Internal Medicine — Payments: $437,610
Brett Atwater, M.d, M.D
Internal Medicine — Payments: $355,531
Kathleen Harnden, M.d, M.D
Internal Medicine — Payments: $173,063
Dr. Daniel Kim, M.d., M.b.a, M.D., M.B.A
Internal Medicine — Payments: $124,814
Dr. Reza Zonozi, M.d, M.D
Internal Medicine — Payments: $118,319
Dr. Elizabeth Held, M.d, M.D
Internal Medicine — Payments: $84,557